Chemomab Therapeutics (CMMB) Return on Capital Employed (QoQ) (2019 - 2025)
Chemomab Therapeutics (CMMB) Return on Capital Employed (QoQ) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Chemomab Therapeutics | 13.62 Mn | 3.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 508.24 Mn |
| Dec 31, 2024 | 240.01 Mn |
| Sep 30, 2024 | -5,619.00 |
| Jun 30, 2024 | 8,834.00 |
| Mar 31, 2024 | 2,345.00 |
| Dec 31, 2023 | 3,880.00 |
| Sep 30, 2023 | 4,282.00 |
| Jun 30, 2023 | 6,772.00 |
| Mar 31, 2023 | 7,952.00 |
| Dec 31, 2022 | 6,320.00 |
| Sep 30, 2022 | 3,047.00 |
| Jun 30, 2022 | 2,057.00 |
| Mar 31, 2022 | -316.00 |
| Dec 31, 2021 | 5,740.00 |
| Sep 30, 2021 | 52.00 |
| Jun 30, 2021 | 1,523.00 |
| Mar 31, 2021 | 9,370.00 |
| Dec 31, 2020 | 91,445.00 |
| Sep 30, 2020 | -46,954.00 |
| Jun 30, 2020 | -16,873.00 |